Patents by Inventor John Girdlestone

John Girdlestone has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Treated Cells and Therapeutic Uses
    Publication number: 20150374755
    Abstract: This invention relates to the use of mesenchymal stem cells in therapy. In particular it relates to a method of preparing the cells with enhanced immunosuppressive property and for use in the treatment of diseases of the immune system.
    Type: Application
    Filed: March 6, 2014
    Publication date: December 31, 2015
    Inventors: John Girdlestone, Cristina Navarrete
  • Method for determining the cell culture history of a cell unit labeled with more than one type of tag
    Patent number: 8318492
    Abstract: The present invention relates in one aspect to a method for determining the cell culture history of a cell unit labelled with more than one type of tag comprising the steps of: (a) measuring one or more parameters of each tag that is used to label the cell unit; (b) identifying each tag in the cell unit; and (c) correlating the identity of each tag to the identity of the cell unit and/or the specific cell culture conditions to which the cell unit has been exposed.
    Type: Grant
    Filed: February 25, 2008
    Date of Patent: November 27, 2012
    Assignee: Plasticell Limited
    Inventors: Yen Choo, Fraser Hornby, John Girdlestone
  • Modulation of HIV infection
    Patent number: 7947469
    Abstract: Disclosed herein are methods and compositions for modulating HIV infection by regulating expression of one or more receptors.
    Type: Grant
    Filed: January 22, 2002
    Date of Patent: May 24, 2011
    Assignee: Gendaq, Ltd.
    Inventors: Michael Moore, Mark Isalan, Lindsey Reynolds, Christopher Ullman, John Girdlestone, Christophe Demaison, Yen Choo
  • Gene regulation II
    Publication number: 20050235369
    Abstract: We describe a transgenic non-human animal comprising a heterologous nucleic acid binding polypeptide which binds to a target gene and modulates its expression, in which the heterologous nucleic acid binding polypeptide is encoded by a transgene, and in which the expression of a target gene in at least one cell is modulated compared to a non-transgenic animal.
    Type: Application
    Filed: March 28, 2002
    Publication date: October 20, 2005
    Inventors: Yen Choo, John Girdlestone, Michael Moore
  • Gene regulation
    Publication number: 20040170619
    Abstract: We describe a method of regulating expression of a nucleic acid sequence in a primary cell, the method comprising providing a nucleic acid binding polypeptide capable of binding to the nucleic acid sequence, and contacting the nucleic acid binding polypeptide with the nucleic acid sequence in the primary cell to regulate its expression. Nucleic acid binding polypeptides capable of binding to and regulating the expression of a nucleic acid sequence in a primary cell is also disclosed.
    Type: Application
    Filed: April 5, 2004
    Publication date: September 2, 2004
    Inventors: John Girdlestone, Nicole England, Christopher Demaison
  • Nucleic acid binding polypeptides
    Publication number: 20040110923
    Abstract: We disclose a polypeptide capable of binding to a nucleic acid comprising a receptor nucleotide sequence.
    Type: Application
    Filed: February 5, 2004
    Publication date: June 10, 2004
    Inventors: Michael Moore, Mark Isalan, Lindsey Reynolds, Christopher Ullman, John Girdlestone, Christophe Demaison, Yen Choo